Brief: Aprea Therapeutics Got Notice From Nasdaq Notifying That Co Did Not Satisfy Certain Continued Listing Requirement
19/08/2022 21:46
Aug 19 (Reuters) - Aprea Therapeutics Inc APRE.O :
* APREA THERAPEUTICS INC - ON AUGUST 15, GOT NOTICE FROM
NASDAQ
NOTIFYING THAT CO DID NOT SATISFY CERTAIN CONTINUED LISTING
REQUIREMENT
Source text for Eikon: [https://bit.ly/3T22v4u]
Further company coverage: APRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing